期刊文献+

WIF-1基因启动子区甲基化在胃癌组织中的检测 被引量:3

Detection of WIF - 1 promoter methylation in gastric cancer
下载PDF
导出
摘要 目的检测胃癌组织及正常胃黏膜组织中WIF-1基因启动子区甲基化情况,并结合临床病理资料,探讨WIF-1基因甲基化状态与胃癌发生、发展的相关性。方法应用甲基化特异性聚合酶链反应(methylation—specinc PCR,MSP)检测30例胃癌组织、30例癌旁组织及10例正常胃黏膜组织中WIF-1基因启动子区甲基化情况。结果胃癌组织、癌旁组织及正常对照组WIF-1基因启动子甲基化阳性率分别为76.6%(23/30)、13.3%(4/30)和0.0%(0/10),胃癌组织甲基化率明显高于后两组,差异有统计学意义(均P〈0.05)。胃癌组织中不同年龄、性别、分化程度的WIF-1基因甲基化阳性率差异均无统计学意义;有淋巴结转移组甲基化率(90%)高于无淋巴结转移组甲基化率(50%),差异有统计学意义(P〈0.05);而Ⅲ~Ⅳ期和Ⅰ~Ⅱ期胃癌组织中WIF-1基因甲基化阳性率分别为90.5%与44.4%,差异有统计学意义(P〈0.05)。结论WIF-1基因启动子区发生高甲基化导致其表达下调或缺失与胃癌的发生、发展以及临床病理特征有着密切的关系,通过MSP法检测胃癌组织及正常组织的甲基化率,为胃癌的早期诊断及综合治疗寻找新的靶点。 Objective To detect the WIF - 1 promoter methylation in gastric cancer tissue and normal gastric mucosa, and to explore its relationship with the development and progress of gastric cancer. Methods Methylation - specific polymerase chain reaction (MSP) was used to detect WIF - 1 promoter methyiation in gastric cancer and tumor -adjacent tissues from 30 gastric cancer patients, and in 10 control specimens from superficial gastritis patients or healthy volunteers. Results In gastric cancer tissue,tumor - adjacent tissue and normal control groups,the WIF- 1 gene promoter methylation positive rate was 76.6% ( 23/30 ), 13.3 % (4/30), 0 ( 0/10 ), respectively. The rate of WIF - 1 promoter methylation was significantly higher in gastric cancer tissue group than that in other two groups ( P 〈 0.05 ). No correlation was found between WIF - 1 gene promoter methylation and age, gender, or tumor differentiation in patients with gastric cancer. And in advanced gastric cancer and early gastric cancer the WIF - 1 gene methylation positive rate was 90.5 % and 44.4%, respectively (P 〈 0. 05 ). Conclusion WIF - 1 gene promoter hyperm- ethylation leading to reduced or absent expression is closely associated with the development,progress and clinical and pathological features of gastric cancer. By using MSP test, detection of the methylation rate of cancer and normal tissues may help find new targets for early diagnosis and treatment of gastric cancer.
出处 《临床外科杂志》 2011年第11期769-771,共3页 Journal of Clinical Surgery
关键词 胃癌 WIF-1基因 甲基化 甲基化特异性聚合酶链反应 stomach neoplasm WIF - 1 gene methylation methylation - specific PCR
  • 相关文献

参考文献9

  • 1Das AV,Bhattacharya S,Zhao X,et al.The canonical Wntpathway regulates retinal stem cells/progenitors in concert with Notch signaling[J].Dev Neurosci,2008,30(6):389-409.
  • 2Garcia MI,Ghiani M,Lefort A,et al.LGR5 deficiency deregulates Wnt signaling and leads to precocious paneth cell differentiation in the fetal intestine[J].Dev Biol,2009,331 (1):58-67.
  • 3Taniguhi H,Yamamoto H,Hirata T,et al.Epigenetic inactivation of Wnt inhibitory factor-l in human gastrointestinal cancers[J].Oncogene,2005,24 (53):7946-7952.
  • 4Mazieres J,He B,You L,et al.Wnt inhibitory factor-1 is silenced by promoter hyperm-ethylation in human lung cancer[J].Cancer Res,2004,64(14):4717-4720.
  • 5Herman JG,Graff JR,Nelkin BD,et al.Methylation-sepeciflc PCR.A novel PCR assay for methylation status of CpG islands[J].Proc Natl Acad Sci U S A,1996,93 (18):9821-9826.
  • 6Cheng XX,Wang ZC,Chen XY,et al.Correlation of Wnt-2 expression and β-catenin intracellular accumulation in Chinese gastric cancers:relevance with tumour dissemination[J].Cancer Letters,2005,223 (2):339-347.
  • 7Lee BB,Lee EJ,Jung EH,et al.Aberrant methylation of APC,MGMT,RASSF2A,and Wif-l genes in plasma as a biomarker for early detection of colorectal cancer[J].Clin Cancer Res,2009,15(19):6185-6191.
  • 8Paluszczak J,Baer-Dubowska W.Epigenetic diagnostics of cancer-the application of DNA methylation markers[J].J Appl Genet,2006,47(4):365-375.
  • 9Lin YC,You L,Xu Z,et al.Wnt signaling activation and WIF-l silencing in nasopharyngeal cancer cell lines[J].Biochem Biophys Res Commun,2006,341 (2):635-640.

同被引文献64

  • 1张松,孔维佳,王彦君,韩月臣,张丹.5-杂氮-2′-脱氧胞苷对人鼻咽癌裸鼠移植瘤的抑制作用[J].癌症,2005,24(10):1201-1205. 被引量:15
  • 2赵润年,刘晓勇,张亚锋.5-氮-2-脱氧胞苷的研究进展[J].实用医技杂志,2006,13(4):554-556. 被引量:1
  • 3陈劲松,梁庆模.Wnt/β-Catenin信号通路与抗癌治疗新靶点[J].中国临床医学,2007,14(1):118-121. 被引量:3
  • 4曾恒,陈安民,李锋,方煌,夏仁云.骨肉瘤诱导分化与多药耐药表型的生物学性状比较[J].中国矫形外科杂志,2007,15(13):1019-1022. 被引量:3
  • 5Niswander LM,Kim SY. Stratifying osteosarcoma:minimizing and maximizing therapy[J].{H}Current Oncology Reports,2010.266-270.
  • 6徐万鹏;冯传汉.骨科肿瘤学[M]{H}北京:人民军医出版社,20086-7.
  • 7Meyers PA,Schwartz CL,Krailo MD. Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group[J].{H}Journal of Clinical Oncology,2008.633-638.
  • 8Peifer M,Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus[J].{H}SCIENCE,2000.1606-1609.
  • 9Guo Y,Rubin EM,Xie J. Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model[J].{H}Clinical Orthopaedics and Related Research,2008,(466):2039-2045.
  • 10Guo Y,Zi X,Koontz Z. Blocking Wnt/LRP5 signaling by a solublereceptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells[J].{H}Journal of Orthopaedic Research,2007,(25):964-971.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部